mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study.
Document Type
Article
Publication Date
4-2022
Publication Title
The Journal of pediatrics
Abstract
In this survey study of institutions across the US, marked variability in evaluation, treatment, and follow-up of adolescents 12 through 18 years of age with mRNA coronavirus disease 2019 (COVID-19) vaccine-associated myopericarditis was noted. Only one adolescent with life-threatening complications was reported, with no deaths at any of the participating institutions.
Volume
243
First Page
208
Last Page
213.e3
Recommended Citation
Kohli U, Desai L, Chowdhury D, Harahsheh AS, Yonts AB, Ansong A, et al [Freij BJ], mRNA coronavirus disease 2019 vaccine-associated myopericarditis in adolescents: a survey study. J Pediatr. 2022 Apr;243:208-213.e3. doi: 10.1016/j.jpeds.2021.12.025. PMID: 34952008
DOI
10.1016/j.jpeds.2021.12.025
ISSN
1097-6833
PubMed ID
34952008